IPO
IPO filing, visualized

ADARx Pharmaceuticals, Inc.

ADRX · Nasdaq424B4 · Sep 28, 2026Priced Sep 24, 2026

Priced Sep 24, 2026 · range was $15–$17 · latest SEC filing Nov 16, 2026.

Pinch-zoom for details.

The offering

Final price
$17.00
per share, from the final prospectus
Shares offered
26.2M
sold by the company
Raise at the final price
$446M
26,250,000 × $17, before fees

What the company does

Not yet summarized; the SEC classifies it as: Pharmaceutical Preparations. See the filing for its business.

Things to weigh

  • The filing's financial tables couldn't be read reliably, so none are shown here.

Risks

The filing doesn't set out its risks in a list we could read.

Strategy

The filing doesn't set out its strategy in a list we could read.

Source: ADARx Pharmaceuticals, Inc.'s Form 424B4, filed with the SEC on Sep 28, 2026 (final prospectus). Figures are as filed; changes are worked out from them. Not investment advice.

10KDecoder10KDecoder.com

10KDecoder (10-K Decoder): decode SEC 10-K filings and IPO prospectuses into dashboards and infographics.